Global Hematology Analyzers and Reagents Market 2019-2023

The growing demand for blood and blood components will be one of the key factors expected to trigger the hematology analyzers and reagents market growth in the forthcoming years. Blood component therapy allows patients for benefitting from one pint of whole blood. Blood and its components are required when the body fails in producing enough blood components for meeting the body’s requirements. As a result, the rising demand for blood and blood components for treating medical conditions is further boosting the demand for hematology analyzers for measuring blood constituents. The analysts have predicted that the hematology analyzers and reagents market will register a CAGR of nearly 6% by 2023.

Market Overview

The rising number of organ transplant procedures

One of the growth drivers of the global hematology analyzers and reagents market is the rising number of organ transplant procedures. During transplantation, red blood cells transfusion is required to support the functioning of the organs which necessitates the need for hematology analyzers.

Lack of adoption of automated hematology analyzer solutions by smaller laboratories

One of the challenges in the growth of global hematology analyzers and reagents market is the lack of adoption of automated hematology analyzer solutions by smaller laboratories. The high cost of the initial set up and instrumentation and the subsequent cost of maintenance are likely to affect the demand for hematology analyzers.

For the detailed list of factors that will drive and challenge the growth of the hematology analyzers and reagents market during 2019-2023, view this report.

Competitive Landscape

The market appears to be moderately concentrated and with the presence of a few market players. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

Preface

Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY END-USER

Market segmentation by end-user

Comparison by end-user

Hospitals and diagnostic centers - Market size and forecast 2018-2023

Blood bank centers - Market size and forecast 2018-2023

Others - Market size and forecast 2018-2023

Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America - Market size and forecast 2018-2023

Europe - Market size and forecast 2018-2023

Asia - Market size and forecast 2018-2023

ROW - Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Abbott

Bio-Rad Laboratories, Inc.

Danaher

F. Hoffmann-La Roche Ltd.

Sysmex Corporation

PART 14: APPENDIX

Research methodology

List of abbreviations

List of Exhibits

Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: End-user - Market share 2018-2023 (%)
Exhibit 18: Comparison by end-user
Exhibit 19: Hospitals and diagnostic centers - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Hospitals and diagnostic centers - Year-over-year growth 2019-2023 (%)
Exhibit 21: Blood bank centers - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Blood bank centers - Year-over-year growth 2019-2023 (%)
Exhibit 23: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Others - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by end-user
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Blood component required for clotting factor deficiency includes:
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Instances of blood use
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Abbott - Vendor overview
Exhibit 48: Abbott - Business segments
Exhibit 49: Abbott - Organizational developments
Exhibit 50: Abbott - Geographic focus
Exhibit 51: Abbott - Segment focus
Exhibit 52: Abbott - Key offerings
Exhibit 53: Bio-Rad Laboratories, Inc. - Vendor overview
Exhibit 54: Bio-Rad Laboratories, Inc. - Business segments
Exhibit 55: Bio-Rad Laboratories, Inc. - Organizational developments
Exhibit 56: Bio-Rad Laboratories, Inc. - Geographic focus
Exhibit 57: Bio-Rad Laboratories, Inc. - Segment focus
Exhibit 58: Bio-Rad Laboratories, Inc. - Key offerings
Exhibit 59: Danaher - Vendor overview
Exhibit 60: Danaher - Business segments
Exhibit 61: Danaher - Organizational developments
Exhibit 62: Danaher - Geographic focus
Exhibit 63: Danaher - Segment focus
Exhibit 64: Danaher - Key offerings
Exhibit 65: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 66: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 67: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 68: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 69: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 70: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 71: Sysmex Corporation - Vendor overview
Exhibit 72: Sysmex Corporation - Business segments
Exhibit 73: Sysmex Corporation - Organizational developments
Exhibit 74: Sysmex Corporation - Geographic focus
Exhibit 75: Sysmex Corporation - Key offerings
Exhibit 76: Validation techniques employed for market sizing

Executive Summary

Global Hematology Analyzers and Reagents Market 2019-2023

The analyst recognizes the following companies as the key players in the global hematology analyzers and reagents market: Abbott, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche Ltd., and Sysmex Corporation.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the rising awareness of blood donations.”

According to the report, one of the major drivers for this market is the rising number of organ transplant procedures.

Further, the report states that one of the major factors hindering the growth of this market is the lack of adoption of automated hematology analyzer solutions by smaller laboratories.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.